Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles

• المؤلفون الرئيسيون: Mahya Mobinikhaledi (مؤلف), Vahid Falahati (مؤلف), Amin Tajerian (مؤلف), Amir Almasi Hashiani (مؤلف), Kazem Ghaffari (مؤلف), Ali Ghasemi (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

BackgroundDeferasirox (DFX) is a once-daily oral iron chelator with proven dose-dependent efficacy in patients with thalassemia major (TM). The reason for switching from DFX dispersible tablets (Exjade®) to DFX film-coated tablets (Jadenu®) was intolerance. Many patients also reported that deferasir...